|
WO2020071935A1
|
|
Choline salts of fumaric acid
|
|
WO2015142206A1
|
|
Water with low deuterium content for the dietary prevention of myocardial infarction
|
|
WO2015142205A1
|
|
Water with low deuterium content for the dietary management of hypertension
|
|
WO2015142209A1
|
|
Water with low deuterium content for the dietary management of psychological distress
|
|
WO2015142210A1
|
|
Water with low deuterium content for the dietary prevention of coronary heart disease
|
|
WO2015142207A1
|
|
Water with low deuterium content for the dietary prevention of stroke
|
|
WO2015142208A1
|
|
Water with low deuterium content for the dietary prevention of tooth loss
|
|
KR20140103289A
|
|
Medical food for the dietary management of depression and anxiety and methods thereof
|
|
US2015313266A1
|
|
Food for the dietary management of burnout
|
|
WO2011099881A1
|
|
Pharmaceutical compositions containing antibodies to neuropeptide head activator and methods thereof
|
|
WO2011099882A1
|
|
Vaccine compositions and methods of use thereof
|
|
UA99789C2
|
|
Choline salts of succinic acid for the treatment of depression, anxiety, schizophrenia, sleep disorder, or epilepsy
|
|
US2011237668A1
|
|
Choline salts of succinic acid for the treatment of depression, anxiety, schizophrenia, sleep disorder, and epilepsy
|
|
WO2010033045A1
|
|
Compositions and methods for prevention or treatment of beta amyloid deposition
|
|
WO2009096807A1
|
|
Pharmaceutical formulation comprising dicholine salt of succinic acid
|
|
WO2009025571A1
|
|
Sublingual or buccal pharmaceutical compositions comprising succinic acid for treating alzheimer's disease
|
|
EA017094B1
|
|
Pharmaceutical compositions for intranasal administration comprising choline salts of succinic acid
|
|
WO2009022932A1
|
|
Pharmaceutical compositions comprising monocholine succinate salts
|
|
US2010160440A1
|
|
Intranasal pharmaceutical compositions comprising succinic acid and methods thereof
|
|
US2009175955A1
|
|
Hydroperoxylapatite and compositions thereof
|
